Levothyrox® new and old formulations: are they switchable for millions of patients?

Concordet, D; Gandia, P; Montastruc, J L; Bousquet-Mélou, A; Lees, P; Ferran, A; Toutain, P L

doi:10.1007/s40262-019-00747-3

Levothyrox® new and old formulations: are they switchable for millions of patients?

Concordet, D; Gandia, P; Montastruc, J L; Bousquet-Mélou, A; Lees, P; Ferran, A; Toutain, P L

Authors

D Concordet

P Gandia

J L Montastruc

A Bousquet-Mélou

P Lees

A Ferran

P L Toutain

Citation

Concordet, D., Gandia, P., Montastruc, J. L., Bousquet-Mélou, A., Lees, P., Ferran, A., & Toutain, P. L. (2019). Levothyrox® new and old formulations: are they switchable for millions of patients?. Clinical Pharmacokinetics, https://doi.org/10.1007/s40262-019-00747-3

Journal Article Type	Article
Acceptance Date	Feb 4, 2019
Publication Date	Apr 4, 2019
Deposit Date	Jan 25, 2019
Publicly Available Date	May 15, 2019
Journal	Clinical Pharmacokinetics
Print ISSN	0312-5963
Electronic ISSN	1179-1926
Publisher	Adis
Peer Reviewed	Peer Reviewed
DOI	https://doi.org/10.1007/s40262-019-00747-3
Public URL	https://rvc-repository.worktribe.com/output/1382869